Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution

BACKGROUND: Immune-oncology agents (IOA) represent a turning point in the treatment of several solid tumors (ST). Although their toxicity compares favorably with other treatments, IOA associate immune-related adverse events (IR-AE), among which endocrine-related AE stand out. We retrospectively eval...

Descripción completa

Detalles Bibliográficos
Autores principales: España, Sofia, Pérez Montes de Oca, Alejandra, Marques-Pamies, Montserrat, Cucurull, Marc, Domenech, Marta, Velarde, José María, Salinas, Isabel, Moran, Teresa, Etxaniz, Olatz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082288/
https://www.ncbi.nlm.nih.gov/pubmed/32206558
http://dx.doi.org/10.21037/tlcr.2019.12.17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082288/
https://www.ncbi.nlm.nih.gov/pubmed/32206558
http://dx.doi.org/10.21037/tlcr.2019.12.17

Ejemplares similares